[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$foyWePA9XjZH0qgKnGJSMpUs__NFax_oAzIeYWzpY6Lc":8,"$fU2gBTUnZnCe7hyKtRWXZv3Mwl992ZZzZhf2Q0qp8tqo":55,"$fnr-7Lvg3iMqT_kzBBppQjBELNZZY9_yLXtkXwJ1kZiA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},46054,863402,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//0Rvlsm1tdkSbq5L99bjhchaojzwJ5kCw.png","华晓萍","浙江大学医学院附属妇产科医院","妇科","主治医师",94,0,"卵巢癌IIIB期高级别浆液性癌常用药品说明：安全用药关键指南","","https://ystcdn.venuertc.com/venue/AI/51e78b01-7f42-4d50-962e-00004a47e09e.jpg","\u003Cdiv class=\"ovarian-medicine-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"ovarian-medicine-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">卵巢癌IIIB期高级别浆液性癌常用药品说明：安全用药关键指南\u003C/h2>\n  \n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg1\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 主要用药分类与作用机制\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      在IIIB期高级别浆液性癌的药物治疗中，临床最常用的药品包括铂类（如顺铂、卡铂）、紫杉醇类，以及部分新型靶向药和辅助用药。每种药物的作用机制各不相同：\n    \u003C/p>\n    \u003Cul class=\"ovarian-medicine-list\">\n      \u003Cli>\u003Cb>铂类药物\u003C/b>（如卡铂）：通过破坏肿瘤细胞DNA，阻止细胞分裂和增殖。\u003C/li>\n      \u003Cli>\u003Cb>紫杉醇类\u003C/b>（如紫杉醇）：抑制微管蛋白的动态变化，使细胞无法顺利完成有丝分裂。\u003C/li>\n      \u003Cli>\u003Cb>靶向药物\u003C/b>（如PARP抑制剂）：利用肿瘤细胞特定的分子标记进行精准打击，抑制癌细胞修复受损DNA的能力。\u003C/li>\n      \u003Cli>\u003Cb>辅助用药\u003C/b>（如护肝药、止吐药）：保障主要治疗药物的顺利使用和减轻不适感。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      正确理解这些药物的基本原理，有助于提升用药依从性与安全性。\u003Cspan class=\"ovarian-medicine-emoji\">💡\u003C/span>\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg2\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 服用时间与方法指导\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      说起来，每一类药品的服用方法其实有很多细节需要患者注意。不同药物的给药途径、给药时间和剂量安排直接影响疗效和安全性。\n    \u003C/p>\n    \u003Cul class=\"ovarian-medicine-list\">\n      \u003Cli>\n        \u003Cb>静脉注射/滴注类药物\u003C/b>（如紫杉醇、卡铂）：\n        \u003Cbr>\n        正确做法：通常由专业医疗人员操作，以防止注射部位不适。多数需定期按疗程静脉给药，需要严格按照治疗周期进行。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>口服靶向药物\u003C/b>（如奥拉帕尼PARP抑制剂）：\n        \u003Cbr>\n        正确做法：需每日按规定时间间隔整片吞服，建议配合足量白开水，尽量每日同一时间服用。饭前饭后依据说明书或医生建议，不可随意更改服药时间。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>辅助口服药品\u003C/b>（如止吐药、护肝药）：\n        \u003Cbr>\n        正确做法：大多需要在饭前或饭后服用，具体依药品说明书操作。如果服药后感到不适，及时和医生沟通。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      节奏掌握得好，有助于减少不良反应，发挥最大疗效。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg3\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 剂型选择与服用技巧\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      药品剂型多样，选对剂型也很关键。\u003Cspan class=\"ovarian-medicine-emoji\">🔬\u003C/span>\n      下面总结典型剂型的服用技巧：\n    \u003C/p>\n    \u003Cul class=\"ovarian-medicine-list\">\n      \u003Cli>\n        \u003Cb>注射剂\u003C/b>（如顺铂、卡铂、紫杉醇）：\u003Cbr>\n        正确做法：静脉滴注速度需严格控制，过程中如出现红肿、刺痛需立即告知医护人员。部分药物需使用特定溶媒或特殊过滤器，不能擅自调整配比。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>口服片剂/胶囊剂\u003C/b>（如奥拉帕尼）：\u003Cbr>\n        正确做法：不可嚼碎或掰开。服用时配温水吞服，避免热饮或碳酸饮料。胶囊剂建议竖直坐姿吞服，减少卡喉风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>辅助药物\u003C/b>（如护肝片、止吐片等）：\u003Cbr>\n        正确做法：务必核查剂型，一些药片不可碾碎；胶囊不要打开服用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      药品剂型选用和服药细节影响药物效果，也能帮助患者远离用药意外。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg4\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 特殊人群的用药关注点\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      其实不同身体状况的人，对药品反应也不一样。特殊人群需特别注意个体差异：\n    \u003C/p>\n    \u003Cul class=\"ovarian-medicine-list\">\n      \u003Cli>\n        \u003Cb>老年人：\u003C/b>建议在医生指导下调整剂量，避免基础疾病影响药物代谢。部分研究提示老年人对紫杉醇、铂类药物的骨髓抑制反应更敏感。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>肝肾功能不全者：\u003C/b>部分药物（如卡铂、靶向药）需调整剂量。特别提醒：肝肾功能不佳时，不应自行停药或增减剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>孕妇、哺乳期女性：\u003C/b>紫杉醇、顺铂等药物禁用于孕期。口服PARP抑制剂哺乳期不推荐使用，需暂停母乳喂养并与医师沟通。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      个体化用药策略可提高疗效、减少风险。如果自己属于这些情况，务必提前说明，以便及时调整用药。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg5\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用与注意事项\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      不少肿瘤用药容易和其它常用药\"打架\"。这里罗列几类常见干扰和对策：\n    \u003C/p>\n    \u003Cul class=\"ovarian-medicine-list\">\n      \u003Cli>\n        \u003Cb>肝酶诱导剂/抑制剂：\u003C/b>如部分抗癫痫药(苯巴比妥)、抗生素(红霉素)会改变紫杉醇、奥拉帕尼的代谢速度。正确做法：同时用药时必须报告医生，由医生判断是否需要调整剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>抗酸药/质子泵抑制剂：\u003C/b>会影响口服类靶向药的吸收效果。用药间隔应至少2小时，避免一起服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>中草药/保健品等：\u003C/b>部分成分与化疗药存在不良联合作用。一定要详细告知医生所有正在使用的药物及保健品名称。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>多药联用时：\u003C/b>需关注药物配伍禁忌，部分药品溶液不宜同瓶混合。遵循药品说明书及医嘱操作。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      按规避开药物冲突，是降低药物不良反应和提升疗效的重要前提。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg6\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 副作用监测与应对方法\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      化疗及靶向药常见副作用依药品不同而不同。比如：\n    \u003C/p>\n    \u003Cul class=\"ovarian-medicine-list\">\n      \u003Cli>\n        \u003Cb>紫杉醇、铂类：\u003C/b>可能导致骨髓抑制、外周神经病变、脱发等。临床研究显示，紫杉醇引起周围神经病变的发生率可达60%\u003Csup>[1]\u003C/sup>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>口服靶向药物（如奥拉帕尼）：\u003C/b>可见恶心、乏力、贫血、肝酶升高。常见不良反应发生率约70%\u003Csup>[2]\u003C/sup>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>辅助药物：\u003C/b>如止吐药易引起胃肠道反应，护肝药过量可能损害肝功能。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      出现轻度副作用时可短时间观察，症状严重或持续恶化应及时就医。正确做法：定期复查血象、肝肾功能，出现严重反应不自行停药，需和医生取得联系。\n    \u003C/p>\n    \u003Cdiv class=\"ovarian-medicine-notes\">\n      \u003Cb>案例提示：\u003C/b>\u003Cbr>\n      有位患者在使用紫杉醇期间出现四肢麻木，及时告知医护后调整方案，避免了进一步加重。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg7\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存及保管提醒\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      药品储存不当，极易影响药效和安全性。下面梳理常用药的储存要点：\n    \u003C/p>\n    \u003Cul class=\"ovarian-medicine-list\">\n      \u003Cli>\n        \u003Cb>注射剂：\u003C/b>通常需保存在2-8℃冰箱中，避免冷冻。运输时注意温度变化。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>口服片剂、胶囊剂：\u003C/b>应密封避光、储存于阴凉干燥处（一般为25℃及以下）。遇到潮湿、变色或过期时禁止服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>辅助用药：\u003C/b>遵照说明书储存温度，并注意定期检查药品有效期。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>过期、损坏药品：\u003C/b>切勿自行丢弃到生活垃圾桶，应交正规回收点处理。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      药品储存得当，能大幅度保证安全性和使用效果。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg8\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服/过量用药的应对措施\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      日常用药少不了会碰到漏服或用量多了的尴尬状况。方法如下：\n    \u003C/p>\n    \u003Cul class=\"ovarian-medicine-list\">\n      \u003Cli>\n        \u003Cb>漏服：\u003C/b>若想起时距离下一次服药还有较长时间，可立即补服一次；但若接近下次服药时间，则不需补服，按原计划继续。不可双倍剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>过量服用：\u003C/b>及时联系医疗人员，并带药品包装前往医疗机构。若身体出现明显不适（如极度乏力、呕吐），切勿拖延。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>静脉注射意外用量：\u003C/b>应立即呼叫护士或医生，由专业人员根据状况处理。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"ovarian-medicine-notes\">\n      \u003Cb>案例提示：\u003C/b>临床中曾有患者因错服两次奥拉帕尼，第一时间求助后未发生严重后果，这也再次说明了及时沟通的重要性。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg9\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 用药案例分析\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      下面以实际用药案例如下，帮助大家理解正确操作的必要性：\n    \u003C/p>\n    \u003Cdiv class=\"ovarian-medicine-case\">\n      一位48岁女性，术后使用卡铂+紫杉醇方案，合并奥拉帕尼辅助治疗。用药期间无严重不良反应，服药规范有序。\u003Cbr>\n      启示：药品依疗程规律使用、注意药物相互作用、做好不良反应监测，是安全用药的基础。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"ovarian-medicine-section ovarian-medicine-bg10\">\n    \u003Ch2 class=\"ovarian-medicine-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 结语与重点回顾\u003C/h2>\n    \u003Cp class=\"ovarian-medicine-paragraph\">\n      \u003Cspan class=\"ovarian-medicine-emoji\">✅\u003C/span>总结一下，卵巢癌IIIB期高级别浆液性癌患者所需药品种类多、用药细节繁琐。\u003Cbr>\n      \u003Cb>关键注意：\u003C/b>药品用法、时间、剂型选择不能出错；及时监测和处理副作用；科学储存药品；漏服、过量要迅速应对。\u003Cbr>\n      真正做到“按疗程、按规范”，既有助于提高治疗效果，也保障了安全。遇到疑问，及时与医生沟通，是明智之选。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"ovarian-medicine-reference\">\n    \u003Ch3 class=\"ovarian-medicine-ref-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Col class=\"ovarian-medicine-ref-list\">\n      \u003Cli>Scripture, C. D., Figg, W. D., &amp; Sparreboom, A. (2006). Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives. Current Neuropharmacology, 4(2), 165-172. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18615133/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n      \u003Cli>Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., ... &amp; Matulonis, U. (2012). Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. New England Journal of Medicine, 366(15), 1382-1392. \u003Ca href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa1105535\" target=\"_blank\">NEJM\u003C/a>\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.ovarian-medicine-wrapper { max-width: 840px; margin: 30px auto; background: #fafcfd; border-radius: 20px; padding: 30px 24px 44px; font-family: 'Segoe UI', 'Microsoft YaHei', Arial, sans-serif;}\n.ovarian-medicine-title { color: #284258; font-size: 34px; margin-bottom: 38px; font-weight: bold; text-align: center; letter-spacing: 1px;}\n.ovarian-medicine-section { border-radius: 16px; margin-bottom: 38px; padding: 32px 26px 22px 26px;}\n.ovarian-medicine-subtitle { color: #28619c; font-size: 26px; margin-bottom: 17px; letter-spacing:0.5px; }\n.ovarian-medicine-paragraph { color: #303447; font-size: 18px; margin-bottom: 14px; font-weight: 400; }\n.ovarian-medicine-list { color: #46495b; font-size: 17px; margin: 0 0 12px 10px; padding-left: 24px; line-height: 1.8;}\n.ovarian-medicine-notes, .ovarian-medicine-case { background: #eaf7ef; border-left: 5px solid #a0dabf; padding: 15px 18px; color: #216c3b; border-radius: 7px; font-size: 16px; margin-bottom: 14px; line-height: 1.6;}\n.ovarian-medicine-emoji { font-size: 19px; margin: 0 4px; }\n.ovarian-medicine-ref-title { color: #206797; font-size: 20px; font-weight: bold; margin-bottom: 7px;}\n.ovarian-medicine-ref-list { font-size: 15px; color: #2e4361; line-height: 1.7; padding-left: 19px;}\n\n.ovarian-medicine-bg1 { background: linear-gradient(92deg, #ecefff 60%, #f2f3fa 100%);}\n.ovarian-medicine-bg2 { background: linear-gradient(100deg, #eaf4fd 55%, #f7faff 100%);}\n.ovarian-medicine-bg3 { background: linear-gradient(80deg, #edf4fb 60%, #f5fafc 100%);}\n.ovarian-medicine-bg4 { background: linear-gradient(82deg, #e7f8f0 60%, #f4fcfa 100%);}\n.ovarian-medicine-bg5 { background: linear-gradient(92deg, #f6f9ec 60%, #fafbfc 100%);}\n.ovarian-medicine-bg6 { background: linear-gradient(88deg, #fff8ed 60%, #fbf7f4 100%);}\n.ovarian-medicine-bg7 { background: linear-gradient(90deg, #edf2fd 60%, #fcfbf6 100%);}\n.ovarian-medicine-bg8 { background: linear-gradient(84deg, #f0f9f5 60%, #f6fbff 100%);}\n.ovarian-medicine-bg9 { background: linear-gradient(85deg, #f9f2fd 60%, #fcfaf9 100%);}\n.ovarian-medicine-bg10 { background: linear-gradient(93deg, #f7fafd 55%, #fff9f5 100%);}\n\u003C/style>\n","\u003Cdiv class=\"ovarian-medicine-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"ovarian-medicine-title\" styl",559,"2025-07-03 18:09:32","卵巢癌, 药品说明, 安全用药, 靶向药物, 副作用监测","本文详细解析卵巢癌IIIB期高级别浆液性癌患者常用药品，包括给药方式、药物相互作用、特殊人群用药注意事项等，帮助患者安全用药，提升治疗效果。","2025-07-04 13:18:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]